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Abstract: Gold nanostars (AuNSs) exhibit modulated plasmon resonance and have a high SERS
enhancement factor. However, their low colloidal stability limits their biomedical application as a
nanomaterial. Cationic β-cyclodextrin-based polymer (CCD/P) has low cytotoxicity, can load and
transport drugs more efficiently than the corresponding monomeric form, and has an appropriate
cationic group to stabilize gold nanoparticles. In this work, we functionalized AuNSs with CCD/P
to load phenylethylamine (PhEA) and piperine (PIP) and evaluated SERS-based applications of the
products. PhEA and PIP were included in the polymer and used to functionalize AuNSs, forming
a new AuNS-CCD/P-PhEA-PIP nanosystem. The system was characterized by UV–VIS, IR, and
NMR spectroscopy, TGA, SPR, DLS, zeta potential analysis, FE-SEM, and TEM. Additionally, Raman
optical activity, SERS analysis and complementary theoretical studies were used for characterization.
Minor adjustments increased the colloidal stability of AuNSs. The loading capacity of the CCD/P
with PhEA-PIP was 95 ± 7%. The physicochemical parameters of the AuNS-CCD/P-PhEA-PIP
system, such as size and Z potential, are suitable for potential biomedical applications Raman and
SERS studies were used to monitor PhEA and PIP loading and their preferential orientation upon
interaction with the surface of AuNSs. This unique nanomaterial could be used for simultaneous
drug loading and SERS-based detection.
Keywords: gold nanostars; cationic β-cyclodextrin-based polymer; phenylethylamine; piperine;
drug co-loading; surface-enhanced Raman scattering
1. Introduction
Gold nanoparticles are employed in bionanotechnology because they exhibit excellent
optoelectronic properties and high surface reactivity, which enable preparation of biocom-
patible nanomaterials with specific functions [1–4]. Bioapplications of gold nanoparticles
include targeted therapy, molecular delivery, imaging, detection, and theranostics [5–7].
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Current studies of gold nanoparticles have focused on their anisotropic forms because
adjustments of the size, morphology and other properties can improve specific charac-
teristics of these nanoparticles. The types of gold nanoparticles include nanorods [8–10],
nanoprisms [11,12], nanocubes [13,14], and nanostars [15–18].
Gold nanostars (AuNSs) are of special interest because morphological modifications,
such as number of tips and their length, can be used to tune the position of the band of
localized surface plasmon resonance [19,20] to place it within a biological window [21,22].
In addition, strong electric field enhancements due to the presence of multiple sharp tips of
AuNSs transform them into high-performance detection materials for surface-enhanced
Raman scattering (SERS) [23,24] and surface-enhanced fluorescence (SEF) [25,26]. Properly
designed AuNSs can be applied for drug delivery and/or photothermal therapy in the
treatment of diseases [16,18] and can be combined with diagnostic mechanisms for surface
enhancement in imaging or detection [15,22,26].
An increase in the reactive surface area due to specific morphology of AuNSs causes
a substantial decrease in colloidal stability [27–29]. Multiple strategies have been tested
to increase the stability and prevent the aggregation of this nanomaterial, such as stabi-
lizing agents containing thiol or amine groups [30,31]. The stabilizing agents may also
have specific new functions, such as detection, therapy, or vectorization. Potential agents
include a wide variety of biomolecules, such as peptides [32], proteins [33,34], genetic mate-
rial [35,36], antibodies [37,38], drugs [39,40], Raman reporters [41,42], fluorophores [26,43],
polymers [44–46], and supramolecular complexes [47].
β-Cyclodextrin (βCD) is a water-soluble nontoxic cyclic oligosaccharide formed by 7
linked units of glucopyranose with a bucket-like shape; this compound has various biomed-
ical applications and is approved by the FDA. The βCD cavity is partially hydrophobic
and can thus incorporate nonpolar species of appropriate dimensions to form an inclusion
complex with increased solubility and protection against oxidation, enzyme-mediated
degradation or photolysis [48,49]. Due to cavity dimensions, βCD is the most commonly
used compound for biological applications, especially drug delivery [50,51]. Additionally,
βCD has been successfully used in association with gold nanoparticles, forming the systems
with potential applications in drug transport [52–55]. However, βCD has lower solubility
than that of α- or γ-cyclodextrins. These factors and cytotoxicity related to βCD binding
to and extraction of cell membrane cholesterol limit the use of βCD [56,57]. Various cy-
clodextrin derivatives have been investigated to overcome these drawbacks [58–60]. These
derivatives include new polymeric forms that were shown to have improved aqueous
solubility and transport efficiency and increased loading capacity for several drugs [61–66].
Notably, βCD-based polymers modified with quaternary ammonium groups were shown
to be ineffective in hosting cholesterol [65,67]. Species with quaternary ammonium group
have been extensively used as stabilizers of AuNPs [68–71]. The interaction of these groups
with AuNPs is electrosteric due to electrostatic interactions between anions (commonly
chloride or bromide) and cations (quaternary ammonium) on the surface of AuNPs and
steric hindrance provided by the organic chain of the species containing quaternary am-
monium [72–75]. Thus, the cationic groups present in the polymer are responsible for
stabilization of AuNSs, leaving multiple βCD cavities of the polymer free to form inclusion
complexes with one or more species through the supramolecular soft-bond chemistry that
defines the host–guest interactions [76,77].
In this work, we synthesized AuNSs using a simple and surfactant-free method. The
prepared nanoparticles produce an absorbance band located within a biological window.
Subsequently, AuNSs were functionalized with a cationic cyclodextrin-based polymer
(CCD/P) to increase their stability over time, forming a new nanomaterial, AuNS-CCD/P.
Phenylethylamine (PhEA) and piperine (PIP) were incorporated in the system to evaluate
drug co-loading capacity and provide a proof-of-concept of the potential SERS application
of the AuNS-CCD/P system.
PhEA is a psychoactive stimulant employed as an antidepressant and does not induce
tolerance. However, PhEA is rapidly metabolized in the body by the MAO-B enzyme
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and thus cannot be accumulated at sufficient concentrations in the brain [78,79]. PIP is
a component of black pepper used as an inhibitor of MAO-A and MAO-B [80,81] that
has antibacterial and insecticidal activity [82], activates the sympathetic system [83] and
facilitates lipolysis in white adipose tissue [84].
This study may contribute to the development of nanotechnology systems based on
AuNSs and CCD/P; these materials have not been reported previously. The new AuNS-
CCD/P system can be used for simultaneous drug loading and in SERS-based detection.
2. Materials and Methods
2.1. Materials
Tetrachloroauric acid (HAuCl4*3H2O) ≥ 99.9%, molar weight: 393.83 g/mol; βCD
(C42H70O35)≥ 98%, 1134.98 g/mol; (±) epichlorohydrin (EP, C3H5ClO)≥ 99%, 92.52 g/mol;
choline chloride (CC, C5H14ONCl) ≥ 98%, 139.62 g/mol; PhEA (1-phenylethan-2-amine,
C8H11N) ≥ 99%, 121.18 g/mol, δ: 0.962 g/mL; PIP ((2E,4E)-5-(2H-1,3-benzodioxol-5-yl)-
1-(piperidin-1-yl)penta-2,4-dien-1-one, C17H19NO3) ≥ 97%, 285.3 g/mol; and sodium
hydroxide (NaOH)≥ 97%, 40.00 g/mol were provided by Sigma Aldrich (Saint Louis, MO,
USA). Hydroxylamine hydrochloride (NH2OH*HCl) ≥ 98%, 69.49 g/mol; hydrochloric
acid (HCl) for analysis, 36.46 g/mol; and water (nanopure) were provided by Merck
(Darmstadt, Germany).
2.2. Synthesis of Gold Nanostars
AuNSs were synthesized according to a protocol reported by Minati et al. [85] with
small adjustments to increase colloidal stability. One milliliter of 100 mmol/L hydroxy-
lamine solution was adjusted to pH 12.3 with NaOH. Subsequently, 100 µL of 10.0 mmol/L
HAuCl4 was added to the solution, under strong and constant agitation. The final con-
centration ratio of hydroxylamine/Au3+ was 100. An instant color change to deep blue
indicated that the reaction was successful. One minute later, the solution was diluted
three-fold to increase colloidal stability in water. Colloidal solution was naturally decanted
for approximately 8 h to form a reversible agglomerate, which was dispersed by sonication,
recovering its color and properties. All procedures were performed at 25 ◦C.
2.3. Synthesis of Cationic β-Cyclodextrin-Based Polymer
CCD/P was synthesized according to the protocol described by Li et al. [58]. Initially,
3.5 mL of aqueous 2.7 mol/L NaOH solution was mixed with 994 mg of βCD inside a
round-bottom distillation flask. A water bath was mounted on an iStir HP550P heating
plate, with magnetic stirring. The flask with the solution was placed inside a water bath
at 25 ◦C and incubated under gentle agitation for 24 h. Then, 125.2 mg of CC was rapidly
added. Subsequently, 1040 µL of EP was added at a flow rate of 30 µL/min for 35 min.
Then, the temperature of the solution was increased to 60 ◦C, and the mixture was stirred
at 52× g for 2 h. The molar ratio of βCD/EP/CC used for the synthesis was 1/15/1. The
reaction was stopped by neutralization with aqueous 3 mol/L HCl solution. The obtained
solution was dialyzed for 24 h. Finally, the resulting polymer was lyophilized to completely
remove the solvent.
2.4. Inclusion of Phenylethylamine and Piperine in Cationic β-Cyclodextrin-Based Polymers
The synthesis of CCD/P-PhEA-PIP was performed using 200 mg of CCD/P, 11.7 µL
of PhEA and 25.14 mg of PIP to achieve a molar ratio of 1/0.5/0.5 since the βCD-PhEA
and βCD-PIP complexes have a 1:1 stoichiometric ratio [55,86]. Aqueous solution of
CCD/P (3 mL) and ethanol solution of PIP (0.5 mL) were prepared. The drug and CCD/P
solutions were slowly mixed and incubated at room temperature for 24 h. These conditions
favored gradual inclusion of both compounds to ensure high occupancy of the hydrophobic
cavity of βCD. Finally, the solution was dialyzed for 24 h to remove unincorporated drug
molecules and lyophilized to obtain the polymer with PhEA and PIP in solid state. All
procedures were performed at 25 ◦C.
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2.5. Functionalization of Gold Nanostars with Cationic β-Cyclodextrin-Based Polymer Loaded
with Phenylethylamine and Piperine
For functionalization with CCD/P-PhEA-PIP, the AuNSs were initially agglomerated,
and the supernatant was removed; subsequently, 1.0 mg of CCD/P-PhEA-PIP dissolved in
3.0 mL of water was added. Then, the system was resuspended by sonication for 3 min.
This procedure was repeated two more times; finally, the AuNS-CCD/P-PhEA-PIP system
was resuspended in water. All procedures were performed at 25 ◦C.
2.6. Characterization of the Systems
AuNSs, CCD/P, CCD/P-PhEA-PIP, AuNS-CCD/P, and AuNS-CCD/P-PhEA-PIP
were characterized using the following approaches.
UV–VIS spectroscopy was performed at 25 ◦C using a UV 2450 spectrophotometer
(Shimadzu, Kyoto, Japan) with water as the baseline. Zeta potential and dynamic light
scattering analyses were performed at 25 ◦C using a Zetasizer (Nano ZS model, Malvern,
Malvern, UK). The size distribution of the samples was determined based on the results
of the intensity distribution values using the cumulant method. The Smoluchowski ap-
proximation was used to calculate the Z potentials based on the measured electrophoretic
mobility. Field emission scanning electron microscopy (FE-SEM) was performed using a
Leo Zeiss Supra 35VP microscope at the acceleration voltages of 15 kV and 2 kV. Transmis-
sion electron microscopy (TEM) was performed using a JEOL 2000FX TEM microscope at
200 kV to determine the average particle size and distribution of the samples. The average
particle size was calculated using Digital Micrograph software. 1H-NMR was performed
using a Bruker Advance 400 MHz superconducting NMR spectrometer at 300 K, and all
solid samples were dissolved in DMSO-d6 (99.99% D). The precursors EP, CC, βCD, PhEA,
and PIP and the samples of CCD/P and CCD/P-PhEA-PIP were measured directly; the
samples of AuNS-CCD/P (10 mg) and AuNS-CCD/P-PhEA-PIP (10 mg) were lyophilized
and then measured. FT/IR spectroscopy was performed using a spectrometer (model
FT/IR-4600, Jasco, Easton, MD, USA). Thermogravimetric analysis (TGA) was performed
using an instrument (model 4000, Perkin-Elmer, Waltham, MA, USA). The temperature
of the furnace was programmed to increase at a rate of 10 ◦C/min from 30 ◦C to 800 ◦C
under an atmosphere of N2 (a flow rate of 20 mL/min). Mass spectrometry was performed
using a MALDI-TOF Microflex (Bruker Daltonics Inc., Billerica, MA, USA) in the positive
and negative ion mode by linear detection in the presence of the DHB matrix. Entrapment
efficiency and loading capacity were determined using an SPR instrument (Dual channel
SR7500DC, Reichert Technologies, Depew, NY, USA) with an autosampler system. Data
acquisition was performed using Integrated SPR Autolink (Reichert Technologies, Depew,
NY, USA). The data were processed using TraceDrawer 1.6.1 and OriginPro 8.0 software.
2.7. Raman and Surface-Enhanced Raman Scattering Measurements
The Raman and SERS measurements were performed using a micro-Raman RM 1000
spectrometer (Renishaw, Wotton-under-Edge, UK) equipped with lasers at 514, 633, and
785 nm. The apparatus was coupled to a DM LM microscope (Leica Microsystems, Wetzlar,
Germany) and an electrically cooled CCD camera (Renishaw, Wotton-under-Edge, UK). The
Raman signal was calibrated to the 520 cm−1 line of silicon using a lens with a 50× objective.
The laser power incident on the sample was approximately 0.2 mW. The acquisition time
was set between 10 and 20 s per accumulation; the average number of accumulations was
10, with a spectral resolution of 4 cm−1. Data were collected between 0 and 3000 cm−1, and
the recorded spectral region was between 200 and 2000 cm−1. The conditions of spectral
recording and laser wavelength were selected to avoid the degradation and possible
fluorescence of the samples; accordingly, the 785 nm laser line was used for SERS and
Raman spectral scanning. Raman spectra of PhEA were measured in samples prepared by
drying of multiple drops of the solution on silica. The Raman spectra of PIP, CCD/P, and
CCD/P-PhEA-PIP were collected in the solid state. The SERS spectra of AuNS-CCD/P
and AuNS-CCD/P-PhEA-PIP were obtained in aqueous solution supported on silica.
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2.8. Molecular Model, Methods, and Calculations for Theoretical Raman Spectra
All calculations were performed using density functional theory (DFT) in Gaussian09,
revision D.01 [87], on a high-performance computing (HPC) cluster. The B3LYP [88,89]
hybrid exchange-correlation functional and 6–311*G(d,p) basis set were used. B3LYP is a
functional suitable for organic molecules [90,91] and is widely used in this field of research
to assign vibrational signals [55,92]. A Gaussian valence triple Z basis set with polarization
and diffuse orbitals for heavy atoms and polarization orbitals for hydrogen atoms was
selected to achieve a good system description with a low basis set incompleteness.
The first step included molecular geometry optimization. Scans over various angles
were performed to identify various local minima. The lowest local minima geometry was
used for each molecule in the gas phase. Additionally, a harmonic vibrational frequency
calculation was performed to verify that the optimized geometries were genuine minima
in the potential energy surface. No symmetry or geometry restrictions were imposed
during the optimizations. The second step included an anharmonic vibrational frequency
and Raman intensity calculations, through second-order vibrational perturbation theory
(VPT2) [93], for previously relaxed structures to obtain a set of vibrational signals for
Raman spectra and their normal modes. This information was used to assign the normal
modes of vibration to experimental Raman data through atomic displacement vectors and
direct visualization.
3. Results and Discussion
3.1. Preparation and Stabilization of Gold Nanostars
Successful production of AuNSs was confirmed using UV–VIS spectroscopy; this
technique allows the evaluation of optical properties of nanoparticles by providing prelimi-
nary information on the size, shape, or state of aggregation, which are associated with the
surface plasmon resonance characteristics of the nanoparticles [94,95]. Figure 1A shows
the spectra with a maximum absorbance at 639 nm and a plasmon bandwidth of 275 nm
characteristic for AuNSs prepared by this method. Additionally, the TEM and FE-SEM
images shown in Figure 1B,C revealed that AuNSs had a central spherical morphology
with multiple short arms [85,96]. The shoulders were not observed, demonstrating the
absence of by-product nanospheres.
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Figure 1. (A) AuNSs absorbance spectrum in triplicate; (B) and (C) TEM and FE-SEM images of
AuNSs, respectively. Scale bars: (B) 100 nm, (C) 2 µm.
Minati et al. [85] reported that AuNSs obtained using hydroxylamine as a reducing
agent were stable for 3 h without other stabilizers; this synthesis was fast and was accom-
plished in less than a minute; however, the procedure does not control particle size and
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cannot produce particles with longer stabilization time. Various minor adjustments to the
synthesis procedure were studied to increase colloidal stability, expand the functionaliza-
tion alternatives and allow the use of generated nanomaterials. Prepared AuNSs were
immediately diluted in water to decrease particle concentration and avoid the aggregation
caused by the Brownian movement. This strategy increased the stability time to at least
seven days and was a fast, simple, and effective means to avoid coating the surface of the
material with stabilizing molecules that may limit surface reactivity and subsequent use of
the particles.
The tested dilution factors ranged from 2× to 10×, and 3×–10× dilutions resulted
in stable AuNSs. Figure 2 shows the changes in the hydrodynamic diameter versus
time (Figure 2A) and the absorbance maxima and plasmon bandwidths of the spectra
(Figure 2B) of AuNSs at various dilutions. The greatest absorbance maximum and lowest
plasmon bandwidth were observed in a sample with a 3× dilution factor, indicating a
higher concentration and smaller size distribution than those in other samples; this dilution
factor was therefore used in the optimized procedure. At this dilution, AuNSs gradually
agglomerated at the bottom of the vial. This process was completely reversed by sonication.
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Figure 2. (A) Hydrodynamic diameter vs. time elapsed from the synthesis of AuNSs at various dilution factors from 1× to
10×; (B) absorbance maxima (left) and plasmon bandwidths (right) of AuNSs in colloidal solution at various dilution factors.
The strategy used to resuspend AuNSs is not trivial. Thus, two methods to resuspend
previously agglomerated AuNSs were compared: sonication and mechanical agitation. The
surface charges of the resuspended colloidal solutions were −49 (±3) mV in the case of
sonication and −55 (±2) in the case of mechanical agitation. The hydrodynamic diameters
were 121 (±18) nm in the first method and 249 (±49) nm in the second method, and
polydispersity indices were 0.22 and 0.34, respectively. The UV–VIS spectra showed an
increase in absorbance, a hypsochro ic shift and a lower plasmon bandwidth in particles
obtained by sonication. Therefore, the mechanical agitation method was not sufficient to
disaggregate colloidal solution after agglomeration, while the sonication method achieved
efficient resuspension. Moreover, comparison of these characteristics with the properties of
AuNSs in the colloidal solution immediately after synthesis indicated that sonication can
nrich AuNSs. Thus, sonication was used for functionalization of the surfac of AuNSs
with CCD/P and f r washing.
Figure 3A shows the loss of plasmon resonance o AuNSs over 8 h due to agglomera-
tion and the recovery of the plasmon resonance signal to the initial value after subsequent
resuspension by sonication. Figure 3B shows the images and FE-SEM micrographs of
the solution after agglomeration and resuspension, demonstrating that AuNSs did not
lose their morphology or surface and optical properties. This process can be repeated for
three consecutive days (for additional details and results, see the supplementary material,
Section S1).
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3.2. Preparation of Cationic β-Cyclodextrin-Based Polymers and Loading with Phenylethylamine
and Piperine
AuNSs were stabilized and functionalized with CCD/P and the PhEA and PIP drugs
to construct a new nanosystem for drug co-loading. Initially, CCD/P was synthesized
according to the protocol of Li et al. [58] via basic reaction of EP with CC and βCD. CCD/P
formation was confirmed using 1H-NMR spectroscopy. Figure 4 shows the spectra and
scheme of the assigned structures of (A) βCD, (B) CC, and (C) EP and the spectrum of
(D) CCD/P. Noticeable changes in the signals corresponding to the hydroxyl groups of
βCD and CC were induced by polymerization of the compounds. Additional chemical
shifts in the H3/H3’ protons of EP (used as a linker) were detected. A widening of the
signals assigned to the internal protons of βCD and protons participating in t e ether-type
bo ds in the region b tween 3.5 and 3 ppm was detected as a result of the formation of the
polymer [97].
CCD/P was also characterized by IR spectroscopy and mass spectrometry. In the IR
spectrum, the attenuation of the band near 3600 cm−1 corresponded to the stretching of the
OH groups, and the changes in the interval from 1050 to 1200 cm−1 corresponded to the
stretching of the ether bonds, suggesting the formation of the ether bonds by the epoxide
moiety of EP attacking hydroxyl groups of CC and βCD [98] in agreement with the NMR
results. The mass spectrum detected variable degrees of polymerization of up to 14 βCD
units in each chain (see figures in the Supplementary Material, Section S2.1).
The PhEA and PIP drugs were used to evaluate the drug inclusion capacity of the
polymers. The resulting loaded CCD/P was used for surface modification of AuNSs.
The inclusion process was characterized using 1H-NMR. Figure 5 shows the spectra of
PhEA, PIP and CCD/P (A, B, and C, respectively) and the assigned structures of PhEA and
PIP. The spectrum (D) shows the signals of the polymer and both drugs, demonstrating
simultaneous inclusion of PhEA and PIP in the cavities of polymerized βCD, forming a
new CCD/P-PhEA-PIP system.
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Integration of the signals corresponding to each drug in the CCD/P-PhEA-PIP system 
showed a stoichiometric relationship corresponding to three-fold higher inclusion of PIP 
than that of PhEA. Furthermore, integration of signals corresponding to βCD cavities of 
CCD/P in the CCD/P-PhEA-PIP system showed a stoichiometric relationship correspond-
ing to 4:1:3 βCD: PhEA:PIP, suggesting strongly that the inclusion of the drugs occurred 
exclusively through the βCD cavities in a 1:1 ratio (additional details are shown in the 
supplementary material, Section S2.2). The association constants for βCD-PhEA and βCD-
PIP at a 1:1 stoichiometry in aqueous solution were previously reported to be 760 M−1 [55] 
and 3244 M−1 [99], respectively. These results may explain preferential inclusion of PIP in 
βCD. 
The NMR spectra provided the details of the inclusion process based on the chemical 
shifts of free PhEA and PIP and compounds interacting with the CCD/P cavities. Table 1 
shows the proton assignments for the drugs and the corresponding chemical shifts. The 
assignments were based on the 1H-NMR studies of PhEA and PIP [55,100]. In the latter 
case, adjustments were used to accurately identify all signals. The proton signals of the 
aryl group of PhEA (Hc, Hd, and He) showed chemical shifts towards higher frequencies, 
and the proton signals of the ethylamine chain (Ha, Hb) showed chemical shifts towards 
lower frequencies. This result suggested that the aryl group of PhEA was completely in-
corporated in the βCD cavity, and the ethylamine chain was close to one of the apertures 
of the matrix and interacted with the hydroxyl groups, as reported previously for the 
βCD-PhEA complex [55]. 
Table 1. Proton assignments and 1H-NMR chemical shifts of free phenylethylamine and piperine and compounds inter-
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The NMR spectra provided the details of the inclusion process based on the chemical
shifts of free PhEA and PIP and compounds interacting with the CCD/P cavities. Table 1
shows the proton assignments for the drugs and the corresponding chemical shifts. The
assignments were based on the 1H-NMR studies of PhEA and PIP [55,100]. In the latter
case, adjustments were used to accurately identify all signals. The proton signals of the
aryl group of PhEA (Hc, Hd, and He) showed chemical shifts towards higher frequencies,
and the proton signals of the ethylamine chain (Ha, Hb) showed chemical shifts towards
lower frequencies. This result suggested that the aryl group of PhEA was completely
incorporated in the βCD cavity, and the ethylamine chain was close to one of the apertures
of the matrix and interacted with the hydroxyl groups, as reported previously for the
βCD-PhEA complex [55].
Table 1. Proton assignments and 1H-NMR chemical shifts of free phenylethylamine and piperine and compounds interacting
with the cavities of cationic β-cyclodextrin-based polymer.
H of PhEA δPhEA(ppm)
δCCD/P-PhEA-PIP





Hb 2.658 2.683 0.025 Ho 1.475 1.475 0
Ha 2.795 2.819 0.024 Hp 1.594 1.594 0
He 7.176 7.171 −0.005 Hn 3.521 - -
Hc 7.205 7.198 −0.007 Hm 6.043 6.040 −0.003
Hd 7.285 7.278 −0.007 Hi 6.671 6.666 −0.005
Hj 6.894 6.893 −0.001
Hl 6.922 6.922 0
Hk 6.961 6.960 −0.001
Hf 6.990/6.850 6.990/6.850 0
Hh/Hg 7.171/7.219 7.165/7.215 −0.006/−0.004
Hp, Ho, Hn, and Hf of PIP showed no displacement, and the Hi, Hh, Hg, Hj, Hk, and
Hm protons showed a chemical shift to a high frequency, indicating dynamic inclusion
by the benzodioxol and ethylene regions, as reported in a previous study on the βCD-PIP
complexes [86,99,100].
Additionally, CCD/P-PhEA-PIP was studied using FT-IR spectroscopy. A major
contribution of the polymer signals was observed in the spectrum (see Figure in the Supple-
mentary Material, Section S2.3). Therefore, Raman spectroscopy provided complementary
and valuable information on the interaction of the drugs included in CCD/P.
The CCD/P and CCD/P-PhEA-PIP systems were also characterized using TGA to
obtain the information on the formation of the polymers and effective inclusion of the drugs
within the polymer matrix based on the changes in their thermal decomposition [101,102].
Figure 6 shows the thermal decomposition curves of native βCD (A), CCD/P (B), and
CCD/P-PhEA-PIP (C).
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Comparison with the thermogram of native βCD indicated fundamental differences
that confirmed CCD/P formation. Specifically, the βCD thermogram showed the first
decomposition of 10% of mass between 0 and 100 ◦C attributed to the loss of water
molecules; this weight loss was not observed in the polymer because the synthesis method
included the removal of water. The second range of the decomposition of βCD was
observed between 300 and 368 ◦C, corresponding to the loss of 69% of the sample mass.
The CCD/P thermogram detected two decomposition ranges from 220 to 406 ◦C and from
497 to 683 ◦C, corresponding to the loss of 61% and 20% of the sample mass, respectively.
The peaks of the derivative curves for CCD/P were detected at 339 and 625 ◦C (see
the Supplementary Material, Section S2.3). This result was due to an increase in the
decomposition temperature of the polymer chains caused by the matrix that corresponded
to an additional displacement peak.
The CCD/P-PhEA-PIP thermogram shows the changes in the decomposition curve
compared with the CCD/P and βCD thermograms. The loss of 6% of the sample mass
was observed at 100 ◦C. This mass loss was due to the inclusion of PhEA and PIP in the
polymers in aqueous solution, which caused the inclusion of water molecules in the cavities.
The second decomposition from 220 to 450 ◦C resulted in the loss of 61% of the sample mass
and corresponded to a peak at 273 ◦C in the derivative curve. The final decomposition from
464 to 650 ◦C corresponded to a peak at 567 ◦C in the derivative curve. An expansion of
the range of the second decomposition and an increase in the total mass loss of the sample
by 7% were attributed to the presence of PhEA and PIP. This effect is typically observed
when βCD cavities harbor the guest molecules [103,104]. Therefore, various techniques
confirmed effective inclusion of PhEA and PIP in CCD/P.
Entrapment efficiency and loading capacity were studied using SPR, considering that
the βCD cavities in the polymer are the only hydrophobic sites with adequate dimensions
to include PhEA and PIP. The studies were performed at the concentrations of PhEA-PIP
from 1.25 to 5.0 mM. The results are shown in the graphs in Figure 7A,B. Entrapment
efficiency was decreased concomitant to an increase in the concentrations of included
drugs and varied between 91 and 76%. The loading capacity was 95% at the maximum
concentration of the drugs added to the system (5.0 mM initial concentration), and this
concentration resulted in a 1:1 molar ratio of the βCD moiety of the polymer and the
drugs. The loading capacity was decreased when lower drug concentrations were used
since the resulting stoichiometric ratios were 1:>1 (additional details are shown in the
Supplementary Material, Section S2.3).
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3.3. Stabilization of Gold Nanostars with Cationic β-Cyclodextrin-Based Polymer and with
Cationic β-Cyclodextrin-Based Polymer Including Phenylethylamine and Piperine
Confirmation of effective inclusion of the drugs in CCD/P enabled the formation
of the AuNS-CCD/P nanosystem, covering the surface of anisotropic nanoparticles with
cationic polymer. The interaction between the gold atoms and quaternary ammonium
groups was demonstrated using SPR (see the Supplementary Material, Section S3.1).
Additionally, this system was simultaneously loaded with two drugs, PhEA and PIP,
forming a new AuNS-CCD/P-PhEA-PIP nanosystem. Both systems were characterized
using UV–VIS spectroscopy, dynamic light scattering, zeta potential analysis and TEM
to evaluate various parameters, such as dimensions, morphology, absorption within a
biological window and surface charge, relevant for future biomedical applications [105,106].
The results are summarized in Table 2.
Table 2. Wavelengths of the absorbance maxima and plasmon bandwidth according to the UV–VIS spectra, hydrodynamic
diameter, polydispersity index (PDI), surface charge, and diameter according to TEM for AuNSs, AuNS-CCD/P, and
AuNS-CCD/P-PhEA-PIP.









AuNSs 639 275 121 ± 18 0.220 −48.9 ± 3.1 83 ± 30
AuNS-CCD/P 610 245 167 ± 36 0.418 −15.9 ± 0.6 87 ± 27
AuNS-CCD/P-PhEA-PIP 618 246 178 ± 39 0.551 −15.5 ± 0.2 78 ± 23
In general, the changes in the plasmon resonance due to functionalization of the sur-
face of gold nanoparticles were detected based on the UV–VIS spectra and demonstrated
that AuNSs were very sensitive to these effects. Interactions with CCD/P and CCD/P-
PhEA-PIP caused hypsochromic shifts of absorbance maxima by 29 and 21 nm, respectively,
and a decrease in the average bandwidth by approximately 30 nm. Consequently, an
increase in the hydrodynamic diameter of AuNSs from 121 nm to 167 nm was induced by
functionalization with CCD/P, and an increase up to 178 nm was induced by functional-
ization of AuNSs with CCD/P-PhEA-PIP. The surface charge of the AuNSs was −49 mV;
this highly negative value resulted in electrostatic repulsion insufficient for stabilization
of anisotropic nanoparticles for more than 2 h. Functionalization of AuNSs with CCD/P
and CCD/P-PhEA-PIP caused a decrease in the surface charge to approximately −15 mV
in both systems due to the interactions with quaternary amino groups (with charge 1+)
of the polymer. Therefore, high colloidal stability (over 7 days) of the AuNS-CCD/P
and AuNS-CCD/P-PhEA-PIP systems was due to the steric impediment provided by the
polymer and the drugs loaded into the polymer, which inhibited the aggregation of the
nanostructures.
Additionally, 1H-NMR and UV–VIS spectra of the AuNS-CCD/P and AuNS-CCD/P-
PhEA-PIP systems demonstrated that the presence of AuNSs did not influence the inclusion
and stability of CCD/P loaded with PhEA and PIP (see the results of 1H-NMR and UV–VIS
spectroscopy in the Supplementary Material, Sections S3.1 and S3.2).
Figure 8 shows the TEM images of (A) AuNSs, (B) AuNSs covered with CCD/P, and
(C) AuNSs covered with CCD/P-PhEA-PIP (see histogram in the Supplementary Material,
Section S3.3). These TEM images demonstrated that functionalization with CCD/P and
subsequent inclusion of PhEA and PIP did not cause aggregation of the colloidal system,
which maintained its size and characteristic morphology. The calculated sizes considered
only the diameter of AuNSs, since Au has a higher electron density than the organic
material (polymers and drugs) that covers the particles; therefore, the organic structures
were not observed by TEM. Thus, the variations in the average size (last column of Table 2)
were within the range of the standard deviation.
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applications of the AuNS-CCD/P system based on monitoring of the species proximal to
the surface of the particles.
3.4. SERS Measurements of Phenylethylamine and Piperine Included on the Surface of Cationic
β-Cyclodextrin-Based Polymer-Functionalized Gold Nanostars
Raman spectroscopy was used to study the co-loading of PhEA and PIP in the AuNS-
CCD/P nanomaterial and to determine important interactions of these drugs with the
gold atoms on the surface of the AuNS-CCD/P-PhEA-PIP system. Figure 9 shows the
Raman spectra of (A) PhEA, (B) PIP, (C) CCD/P, and (D) CCD/P-PhEA-PIP and the SERS
spectra of (E) AuNS-CCD/P and (F) AuNS-CCD/P-PhEA-PIP. Rigorous theoretical work
was performed to assign molecular vibrations of the Raman and SERS spectra using two
approaches, B3LYP and B3LYP/VPT2, to obtain full harmonic spectra and full anharmonic
spectra, respectively. Then, the VPT2 approach was used to correct overestimated (by 4–5%)
harmonic fundamental DFT frequency with respect to the experimental frequency values;
furthermore, VPT2 can recover the first overtones and combination bands (C.B.) because
not all signals assigned by the harmonic calculation correspond to fundamental vibrations
in the experimental vibrational spectra (additional details are shown in the Supplementary
Material, Sections S4 and S5).
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Figure 9. Raman spectra of (A) PhEA, (B) PIP, (C) CCD/P, and (D) CCD/P-PhEA-PIP; SERS spectra
of (E) AuNS-CCD/P and (F) AuNS-CCD/P-PhEA-PIP.
The Raman spectra of PhEA (A) and PIP (B) were directly compared to the SERS
spectrum of AuNS-CCD/P-PhEA-PIP (F). The CCD/P (C) and CCD/P-PhEA-PIP (D)
systems showed similar Raman spectra; thus, it was not possible to assign or recognize the
signals of both drugs. The registered signals and their assignments are shown in Table 3.
Pharmaceutics 2021, 13, 261 14 of 21
Table 3. Experimental and theoretical Raman signals of PhEA and PIP, SERS bands of the AuNS-CCD/P-PhEA-PIP system
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1597 1583 1602 -C=C aryl ringsymmetrical stretching 1302 1312 1299 -Diene chain H scissoring
1617 1602 1614 -C=C aryl ringsymmetrical stretching 1376 1360 1369 -Diene Chain H rocking
1457 — 1459 ——
1595 1599 1590




and diene chain bending; (ii)
piperidine aliphatic chain H
twisting and diene chain
H rocking
1610 1606 1614
-C. B.: (i) Piperidine aliphatic
chain H rocking, diene chain
bending and aryl ring
bending deformation; (ii)
piperidine aliphatic chain H
twisting, C-C diene chain
stretching and aryl ring
H scissoring
1636 1635 1637
-C. B.: (i) C-C-C piperidine
aliphatic chain bending; (ii)
diene chain H rocking, aryl
ring hydrogen scissoring and
methylene dioxy group
H twisting


























-C. B.: (i) Piperidine aliphatic
chain H rocking and
N-C(=O)-C amide group
bending; (ii) piperidine
aliphatic chain H twisting,
C-C diene chain stretching
and aryl ring H scissoring
In the case of PhEA, the signal at 829 cm−1 corresponded to amine H wagging, which
shifted to 827 cm−1 due to the interaction of the amino groups with the AuNSs surface.
The other signals corresponded to the vibrations associated with the aryl rings, which were
displaced due to the inclusion in the CCD/P. The vibrations at 1009, 1040, 1164, 1597, and
1617 cm−1 in the PhEA spectra were detected and were parallel to the aryl axis.
In the SERS spectrum, the two signals corresponding to the C=C symmetrical bending
and to H rocking with deformation of the aryl ring were shifted to 1008 and 1036 cm−1,
respectively, corresponding to the most intense signals. This result suggests that PhEA
included in CCD/P was oriented perpendicular (⊥) to the AuNSs surface probably due to
the NH2–Au interactions.
The signals at 1111, 1237, 1302, and 1376 cm−1 were related to the H vibrations of the
aryl and diene groups, and these signals were displaced in the SERS spectra due to the
inclusion of PIP onto CCD/P.
The signals at 1122, 1141, 1595, 1610, 1636, and 1645 cm−1 in the PIP spectrum
corresponded to the combined bands of piperidine, aryl and aliphatic vibrations. The
signals at 1590, 1614, and 1637 cm−1 were the major peaks of PIP in the SERS spectra.
These vibrations were not in a single plane, and changes in their intensity, disappearance
or displacement were attributed to a parallel (‖) orientation to the surface of AuNS due to
dynamic inclusion of PIP in CCD/P.
The SERS spectrum of the AuNS-CCD/P system had a signal at 293 cm−1, which was
displaced to 297 cm−1 in the AuNS-CCD/P-PhEA-PIP spectrum. This signal corresponded
to vibrations derived from the interaction between AuNSs and CCD/P.
The differences in the SERS and Raman spectra, mainly in the relative intensity and
wavenumber shifts, were related to different orientations of the analytes on the AuNSs
surface according to SERS selection rules [107,108]. Therefore, the PhEA and PIP molecules
were identified using SERS. Additionally, both drugs acquired a preferential orientation
upon inclusion in the polymer and interaction with the surface atoms of AuNSs. A scheme
of the AuNS-CCD/P-PhEA-PIP system based on the information provided by SERS and
other techniques is shown in Figure 10.
Highly anisotropic nanoparticles, such as AuNSs, have high SERS enhancement
factors [109–111]. Thus, the information obtained in this study was complemented by
a rigorous theoretical analysis; this approach is effective for identification of molecules
located near the surface of the gold atoms and may be used to evaluate their spatial
orientation, which may be relevant for the construction of nanosystems for biomedical
applications using SERS-based detection and/or imaging.
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4. Conclusions
Minor adjustments to the reported method of AuNS synthesis increased colloidal
stability of the particles over time. Spontaneous agglo eration and resuspension enabled
functionalization and purification of AuNSs. CCD/P was used to functionalize AuNSs
and effectively load the PhEA and PIP drugs to generate a new AuNS-CCD/P-PhEA-PIP
nanomaterial. Loading of the drugs in the polymer was 95 ± 7%. The highly anisotropic
surface of AuNSs enabled the investigation of the composition, interaction and orientation
of both drugs in the nanosystem using SERS. Thus, this unique nanomaterial can be used
for simultan ous drug loading and in the studies of SERS-based detection, leading to
potential applications in therapeutic drug monitoring or thera ostics.
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